Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: ITGB1-DT/ARNTL2 axis may be a novel biomarker in lung adenocarcinoma: a bioinformatics analysis and experimental validation

Fig. 2

Role of SLC2A1 in LUAD. A The expression of SLC2A1 in unpaired pan-cancer tissues (* < 0.05, ** < 0.01, *** < 0.001). B The expression of SLC2A1 in paired pan-cancer tissues (* < 0.05, ** < 0.01, *** < 0.001). C The immunohistochemistry of SLC2A1 in LUAD. D The overall survival and disease-free survival of SLC2A1 in LUAD patients (OS: p < 0.001, HR: 1.80 (1.35–2.39); DFS: p < 0.001, HR: 1.62 (1.25–2.11))

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us